Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin, Cyclophosphamide, and Rituximab (PCR) in CLL and SLL
NCT00049413Phase 2Completed
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Start
- Jun 2002
- Primary completion
- Dec 2004
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pentostatin, cyclophosphamide, rituximab in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Hoag Memorial Hospital Presbyterian. Started Jun 2002; status: completed.
02
Drugs
pentostatincyclophosphamiderituximab
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00049413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049413.